fbpx

All Doctor Directory

  • James N. Kochenderfer, M.D.

    Position: Investigator at NIH Research Focus: CAR T cell therapy for multiple myeloma. Dr. Kochenderfer was the first to develop anti-BCMA CAR T cells, and his work focuses totally on developing new CAR T-cell therapies and conducting clinical trials of CAR T-cell therapies.  

  • Srinivas Devarakonda, MD

    Position: Assistant Professor at The Ohio State University Wexner Medical Center Research Focus: Dr. Devarakonda is a hematologist and instructor in the Division of Hematology. He is an internal medicine specialist in Shreveport, LA and specializes in internal medicine.  

  • Abdullah Khan, MBBS

    Position: Dr. Abdullah Khan is an internist in Columbus, Ohio and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. Research Focus:Dr. Khan is a hematologist specializing in multiple myeloma and related plasma cell disorders. General Read more [...]

  • Seema Bhat, MD

    Position: Dr. Seema Bhat is an oncologist in Columbus, Ohio and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. Research Focus: Dr. Bhat is a hematologist she is specializes in treating patients with chronic lymphocytic Read more [...]

  • Naresh Bumma, MD

    Position: Assistant Professor, Department of Internal Medicine, Division of Hematology Research Focus:Multiple myeloma, Light chain amyloidosis, amyloidosis, autologous stem cell transplant, Immunotherapy, cancer genomics.  

  • Terri Parker, MD

    Position: Assistant Professor of Medicine (Hematology) at Yale Cancer Center. Research Interests: Hematology Research Summary: Dr. Parker is a medical oncologist with a research interest in chronic lymphocytic leukemia. She is involved in research and clinical care including clinical trials.

  • Natalia Neparidze, MD

    Position: Assistant Professor of Medicine (Medical Oncology) at Yale Cancer Center. Research Interests: Amyloidosis; Hematology; Leukemia, Plasma Cell; Waldenstrom Macroglobulinemia; Multiple Myeloma; Myeloma Proteins; Paraproteinemias; Neoplasms, Plasma Cell; Smoldering Multiple Myeloma. Research Summary: Clinical trials in multiple myeloma, with specific interests in advanced imaging, tumor heterogeneity and tumor resistance in Read more [...]

  • Noffar Bar, MD

    Position: Assistant Professor of Medicine (Hematology) at Yale School of Medicine Research Summary: Dr. Bar is a member of the American Society of Clinical Oncology as well as the American Society of Hematology. She currently has grant support through the Conquer Cancer Foundation’s Young Investigator Award for her work looking Read more [...]

  • Dr. Pallawi Torka

    Position: Co-Program Director, Hematology Oncology Fellowship Program Research Focus: Dr. Pallawi Torka research focuses on lymphoproliferative cancers i.e. lymphoma and myeloma. Being part of a comprehensive cancer center such as Roswell Park Comprehensive Cancer Center gives me the privilege of applying novel research principles and using promising drugs for treatment Read more [...]

  • Dr. Sumit Madan, MD

    Position: Hematologist/Oncologist Research Interests: Dr. Madan is board certified and fellowship trained hematologist and oncologist specializing in treating multiple myeloma, amyloidosis and waldenstrom macroglobulinemia. He was awarded an endowed research (Kurtz) fellowship in multiple myeloma at Mayo Clinic in Rochester, Minnesota for two consecutive years prior to starting his clinical Read more [...]

  • Satish Shanbhag, MD MPH FACP

    Position: Associate Professor of Medicine and Oncology Johns Hopkins University School of Medicine Clinical Director of Hematology, JHBMC Co-medical Director of Sidney Kimmel Comprehensive Cancer center at JHBMC Research Focus: Amyloidosis, myeloma, POEMS syndrome, lymphoma, Waldenstrom macroglobulinemia, CLL, lymphomas

  • Jens Hillengass, MD

    Position: Chief of Myeloma, Professor of Oncology Research Interest: Imaging in myeloma, physical exercise in myeloma, myeloma bone disease, early stages of plasma cell disorders, minimal residual disease assessment, genomic heterogeneity

  • Tara Gregory, MD

    Position: Member of the American Society of Hematology, The American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation. Research Focus: New therapies and drug development in multiple myeloma.

  • Tara Gregory, MD

    Position: Member of the American Society of Hematology, The American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation. Research Focus: New therapies and drug development in multiple myeloma.

  • Jeffrey Matous, MD

    Position: Medical director for the Colorado Blood Cancer Institute, Clinical professor of medicine at the University Of Colorado Health Sciences Center, Board of the Leukemia-Lymphoma Society. Research Focus: New therapies and drug development in multiple myeloma.

  • Jeffrey Matous, MD

    Position: Medical director for the Colorado Blood Cancer Institute, Clinical professor of medicine at the University Of Colorado Health Sciences Center, Board of the Leukemia-Lymphoma Society. Research Focus: New therapies and drug development in multiple myeloma.

  • Cesar Rodriguez Valdez, MD

    Position: Myeloma Program Leader, Assistance Professor of Medicine and Associate Maya Angelou Center for Health Equity, Stem Cell Transplant and Cell Therapy Program Research Focus: Precision medicine in plasma cell disorders Bone marrow microenvironment Chemoresistance of myeloma cells Translational clinical trials

  • Cesar Rodriguez Valdez, MD

    Position: Myeloma Program Leader, Assistance Professor of Medicine and Associate Maya Angelou Center for Health Equity, Stem Cell Transplant and Cell Therapy Program Research Focus: Precision medicine in plasma cell disorders Bone marrow microenvironment Chemoresistance of myeloma cells Translational clinical trials

  • Edward N. Libby, MD

    Position: Associate Professor, Medical Oncology Division, University of Washington School of Medicine, Associate Member, Clinical Research Division, Fred Hutch Research Focus: Dr. Edward N. Libby’s practice and research focus are in clinical trials for patients with multiple myeloma, Waldenström macroglobulinemia and amyloidosis. Additional Resources: Dose Escalation Study to Investigate the Read more [...]

  • Edward N. Libby, MD

    Position: Associate Professor, Medical Oncology Division, University of Washington School of Medicine, Associate Member, Clinical Research Division, Fred Hutch Research Focus: Dr. Edward N. Libby’s practice and research focus are in clinical trials for patients with multiple myeloma, Waldenström macroglobulinemia and amyloidosis. Additional Resources: Dose Escalation Study to Investigate the Read more [...]

  • Damian Green, MD

    Position: Associate Member, Fred Hutchinson Cancer Research Center, Associate Professor, Medical Oncology, University of Washington School of Medicine . Research Focus: Dr. Damian Green is a translational research physician focused on offering the best available care to patients with multiple myeloma, while developing new treatments to improve outcomes. Dr. Damian Read more [...]

  • Damian Green, MD

    Position: Associate Member, Fred Hutchinson Cancer Research Center, Associate Professor, Medical Oncology, University of Washington School of Medicine . Research Focus: Dr. Damian Green is a translational research physician focused on offering the best available care to patients with multiple myeloma, while developing new treatments to improve outcomes. Dr. Damian Read more [...]

  • Pamela S. Becker, MD, PHD

    Position: Hematologist, Seattle Cancer Care Alliance Professor, Hematology Division, University of Washington School of Medicine Research Focus: I prefer to treat patients on investigational therapy or by accepted guidelines when applicable, but will individualize therapy when the usual treatments have already been given. Clinical Expertise : Plasma cell leukemia, acute Read more [...]

  • Pamela S. Becker, MD, PHD

    Position: Hematologist, Seattle Cancer Care Alliance Professor, Hematology Division, University of Washington School of Medicine Research Focus: I prefer to treat patients on investigational therapy or by accepted guidelines when applicable, but will individualize therapy when the usual treatments have already been given. Clinical Expertise : Plasma cell leukemia, acute Read more [...]

  • David Coffey, MD

    Position: Acting Instructor, University of Washington School of Medicine Philosophy: I strive to deliver compassionate care of the highest quality to each of my patients. My treatment recommendations are based on the best available research and are tailored to each of my patients according to their unique values and preferences. Read more [...]

  • David Coffey, MD

    Position: Acting Instructor, University of Washington School of Medicine Philosophy: I strive to deliver compassionate care of the highest quality to each of my patients. My treatment recommendations are based on the best available research and are tailored to each of my patients according to their unique values and preferences. Read more [...]

  • Andrew J. Cowan, MD

    Position: Assistant Professor, University of Washington Philosophy: In treating patients with cancer, I see the physician-patient relationship as a team. I work closely with patients to create an individual treatment plan, incorporating the best of recent advances. I see my role as that of teacher, coach, and advisor, to help Read more [...]

  • Andrew J. Cowan, MD

    Position: Assistant Professor, University of Washington Philosophy: In treating patients with cancer, I see the physician-patient relationship as a team. I work closely with patients to create an individual treatment plan, incorporating the best of recent advances. I see my role as that of teacher, coach, and advisor, to help Read more [...]

  • Ankit Kansagra, MD

    Position: Assistant Professor of Medicine, UT Southwestern Medical Center and Director of the Outpatient Stem Cell Transplant Program Research Focus: Plasma Cell disorders including Multiple Myeloma, Amyloidosis and Waldenström Macroglobulinemia. Dr. Kansagra focuses on cellular therapies including CAR T therapy and other immunotherapy and outcomes research. 

  • Ankit Kansagra, MD

    Position: Assistant Professor of Medicine, UT Southwestern Medical Center and Director of the Outpatient Stem Cell Transplant Program Research Focus: Plasma Cell disorders including Multiple Myeloma, Amyloidosis and Waldenström Macroglobulinemia. Dr. Kansagra focuses on cellular therapies including CAR T therapy and other immunotherapy and outcomes research. 

  • Dr. Artur Jurczyszyn

    Position: Associate Professor in Medicini Department of Hematology at the Jagiellonian Univeristy Medical College in Cracow and Dean`s Proxy and Chairman of the Kraków Branch Polish Society of Haematology and Blood Transfusion and President of The Myeloma Treatment Foundation Centre Research Focus: My area of research are rare clinical situations in Read more [...]

  • Dr. Artur Jurczyszyn

    Position: Associate Professor in Medicini Department of Hematology at the Jagiellonian Univeristy Medical College in Cracow and Dean`s Proxy and Chairman of the Kraków Branch Polish Society of Haematology and Blood Transfusion and President of The Myeloma Treatment Foundation Centre Research Focus: My area of research are rare clinical situations in Read more [...]

  • Leyla Shune, MD

    Position:  Assistant Professor Research Interests: Umbilical Cord Blood Transplantation | Blood & Marrow Transplantation | Haplotype Mis-Matched Allograft Transplantation | Leukemia | Lymphoma | Myeloma I Allogeneic Stem Cell Transplantation | High Risk Allogeneic Stem Cell Transplantation | Cellular | Immunotherapy | Hematology (malignant & non-malignant disorders) | Stem Cell Read more [...]

  • Leyla Shune, MD

    Position:  Assistant Professor Research Interests: Umbilical Cord Blood Transplantation | Blood & Marrow Transplantation | Haplotype Mis-Matched Allograft Transplantation | Leukemia | Lymphoma | Myeloma I Allogeneic Stem Cell Transplantation | High Risk Allogeneic Stem Cell Transplantation | Cellular | Immunotherapy | Hematology (malignant & non-malignant disorders) | Stem Cell Read more [...]

  • Brian McClune, DO

    Position: Assistant Professor Research Interests: Plasma Cell Disorders | BMT Patient Long-Term Survivorship | Clinical Trials for Hematologic Malignanices. Clinical Interests: Umbilical Cord Blood Transplantation | Blood and Marrow Transplantation | Allogeneic Stem Cell Transplantation | Haplotype Mis-Matched Allograft Transplantation | Hematological Malignancies | Lymphoproliferative Disorders Autoimmune Diseases | Leukemia Read more [...]

  • Brian McClune, DO

    Position: Assistant Professor Research Interests: Plasma Cell Disorders | BMT Patient Long-Term Survivorship | Clinical Trials for Hematologic Malignanices. Clinical Interests: Umbilical Cord Blood Transplantation | Blood and Marrow Transplantation | Allogeneic Stem Cell Transplantation | Haplotype Mis-Matched Allograft Transplantation | Hematological Malignancies | Lymphoproliferative Disorders Autoimmune Diseases | Leukemia Read more [...]

  • Al-Ola Abdallah, MD

    Position: Assistant Professor of Internal Medicine, Director, Plasma Cell Disorder Clinic Research Focus:  My research focus on development of novel therapeutics for the treatment of multiple myeloma, immunotherapy, understating the biology of high risk myeloma patients.

  • Al-Ola Abdallah, MD

    Position: Assistant Professor of Internal Medicine, Director, Plasma Cell Disorder Clinic Research Focus:  My research focus on development of novel therapeutics for the treatment of multiple myeloma, immunotherapy, understating the biology of high risk myeloma patients.

  • Dr. Shahzad Raza, MD

    Position: Director of Malignant Hematology Program/Saint Luke’s Cancer Institute Research: Dr. Shahzad Raza’s research interests include incorporation of monoclonal immunotherapy in combination of IMiDs and proteasome inhibitor in the management of multiple myeloma and formulate personalized treatment care plan for these patients. We are also studying proteomic characteristics in multiple Read more [...]

  • Dr. Shahzad Raza, MD

    Position: Director of Malignant Hematology Program/Saint Luke’s Cancer Institute Research: Dr. Shahzad Raza’s research interests include incorporation of monoclonal immunotherapy in combination of IMiDs and proteasome inhibitor in the management of multiple myeloma and formulate personalized treatment care plan for these patients. We are also studying proteomic characteristics in multiple Read more [...]

  • Sundar Jagganath, MD

    Position: Director of the Multiple Myeloma Program, Professor of Medicine, Hematology and Medical Oncology Research Focus: Sundar Jagannath, MD, is Director of the Multiple Myeloma Program and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute. Dr. Jagannath is a renowned expert in the research and treatment Read more [...]

  • Sundar Jagganath, MD

    Position: Director of the Multiple Myeloma Program, Professor of Medicine, Hematology and Medical Oncology Research Focus: Sundar Jagannath, MD, is Director of the Multiple Myeloma Program and Professor of Medicine (Hematology and Medical Oncology) at The Tisch Cancer Institute. Dr. Jagannath is a renowned expert in the research and treatment Read more [...]

  • Bart Barlogie, MD

    Position: Senior Faculty Research Focus: Dr. Bart Barlogie recently joined the Icahn School of Medicine at Mt. Sinai in New York as Director of Myeloma Research. He had previously headed the Myeloma Institute at the University of Arkansas for Medical Sciences, which he founded 26 years ago. Under his leadership, Read more [...]

  • Bart Barlogie, MD

    Position: Senior Faculty Research Focus: Dr. Bart Barlogie recently joined the Icahn School of Medicine at Mt. Sinai in New York as Director of Myeloma Research. He had previously headed the Myeloma Institute at the University of Arkansas for Medical Sciences, which he founded 26 years ago. Under his leadership, Read more [...]

  • Ajai Chari, MD, PHD

    Position: ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology Research Focus:Dr Chari is an Associate Professor of Medicine, the Director of Clinical Research in the Multiple Myeloma Program, and the Associate Director of Clinical Research, Mt Sinai Cancer Clinical Trials Office. Clinical Interests: Plasma cell disorders, including multiple myeloma, AL amyloidosis, Read more [...]

  • Ajai Chari, MD, PHD

    Position: ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology Research Focus:Dr Chari is an Associate Professor of Medicine, the Director of Clinical Research in the Multiple Myeloma Program, and the Associate Director of Clinical Research, Mt Sinai Cancer Clinical Trials Office. Clinical Interests: Plasma cell disorders, including multiple myeloma, AL amyloidosis, Read more [...]